Nuvectis Pharma Inc.

NASDAQ: NVCT · Real-Time Price · USD
9.02
-0.39 (-4.14%)
At close: Jun 02, 2025, 3:59 PM
9.42
4.43%
After-hours: Jun 02, 2025, 04:21 PM EDT

Nuvectis Pharma Statistics

Share Statistics

Nuvectis Pharma has 20.89M shares outstanding. The number of shares has increased by 27.43% in one year.

Shares Outstanding 20.89M
Shares Change (YoY) 27.43%
Shares Change (QoQ) 21.07%
Owned by Institutions (%) 7.67%
Shares Floating n/a
Failed to Deliver (FTD) Shares 871
FTD / Avg. Volume 0.64%

Short Selling Information

The latest short interest is 2.1M, so 10.06% of the outstanding shares have been sold short.

Short Interest 2.1M
Short % of Shares Out 10.06%
Short % of Float 19.46%
Short Ratio (days to cover) 15.36

Valuation Ratios

The PE ratio is -4.87 and the forward PE ratio is -8.79. Nuvectis Pharma's PEG ratio is 0.22.

PE Ratio -4.87
Forward PE -8.79
PS Ratio 0
Forward PS 1.6
PB Ratio 9.53
P/FCF Ratio -7.56
PEG Ratio 0.22
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Nuvectis Pharma.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.

Current Ratio 2.09
Quick Ratio 2.09
Debt / Equity 0
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-1,461,538.46
Employee Count 13
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 37.92% in the last 52 weeks. The beta is -0.12, so Nuvectis Pharma's price volatility has been lower than the market average.

Beta -0.12
52-Week Price Change 37.92%
50-Day Moving Average 9.41
200-Day Moving Average 7.27
Relative Strength Index (RSI) 44.39
Average Volume (20 Days) 135,687

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -19.85M
Net Income -19M
EBITDA -19M
EBIT -19M
Earnings Per Share (EPS) -1.11
Full Income Statement

Balance Sheet

The company has 18.53M in cash and 0 in debt, giving a net cash position of 18.53M.

Cash & Cash Equivalents 18.53M
Total Debt n/a
Net Cash n/a
Retained Earnings -73.25M
Total Assets 30.15M
Working Capital 20.95M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.25M and capital expenditures 0, giving a free cash flow of -12.25M.

Operating Cash Flow -12.25M
Capital Expenditures n/a
Free Cash Flow -12.25M
FCF Per Share -0.72
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NVCT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for NVCT is $17, which is 88.5% higher than the current price. The consensus rating is "Buy".

Price Target $17
Price Target Difference 88.5%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Scores

Altman Z-Score 7.82
Piotroski F-Score 2